Wes Kaupinen

Insider Reports History

Entity
Individual
Location
C/O Palvella Therapeutics, 125 Strafford Drive, Wayne, PA
Signature
Kathleen A. McGowan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wes Kaupinen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PIERIS PHARMACEUTICALS, INC. President and CEO, Director, 10%+ Owner Common Stock 781K $12.4M $15.88 Dec 13, 2024 by Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019
PIERIS PHARMACEUTICALS, INC. President and CEO, Director, 10%+ Owner Common Stock 781K $12.4M $15.88 Dec 13, 2024 by Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019
PIERIS PHARMACEUTICALS, INC. President and CEO, Director, 10%+ Owner Common Stock 42.9K $682K $15.88 Dec 13, 2024 Direct
PIERIS PHARMACEUTICALS, INC. President and CEO, Director, 10%+ Owner Stock Option (right to buy) 418K Dec 13, 2024 Direct

Insider Reports Filed by Wes Kaupinen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PVLA PALVELLA THERAPEUTICS, INC. Dec 13, 2024 1 $0 4 Dec 17, 2024 President and CEO, Director, 10%+ Owner
PVLA PALVELLA THERAPEUTICS, INC. Dec 13, 2024 0 $0 3 Dec 16, 2024 President & CEO, Director, 10%+ Owner